Sam is a trader and one of our lead stock analysts at AskTraders. After starting his career predominantly in the forex markets, Sam now focuses on gold and stocks with a preference for macroeconomic analysis.
Remote Monitored Systems (LON: RMS) shares are trading lower on Monday despite announcing it has signed a deal with PIC Consultants.
The deal will see the company supply a new range of retail hydroponic nutrients for distribution into the UK hydroponics market.
The range consists of eight solutions, which contain patented nanoparticles produced by the company's subsidiary, Pharm 2 Farm, and will be marketed throughout the UK and Ireland under the nano.10-9 brand.
Hydroponics involves growing plants in sand, gravel, or liquid, with added nutrients but without soil. RMS said it feels hydroponics a potential solution for the growing concern about food security.
RMS said the patented nanoparticles have demonstrated to be an improved alternative to common mineral fertilisers, including ethylenediaminetetraacetic acid (EDTA) chelates.
PIC has agreed over the next 12 months to purchase a minimum of 40,000 litres of the eight solutions in the nano.10-9 range, with expected revenue for RMS of around £80,000. However, the company expects this to grow significantly as the market becomes more aware of the benefits.
“We are delighted to have entered into this agreement with PIC which reflects the excellent demand we perceive for Pharm 2 Farm's high-quality nano particles in the hydroponics sector and also demonstrates the breadth of applications where our nano particles can benefit the end-user,” said Antony Legge, Executive Chairman of RMS.
RMS' share price is currently down 2.8% at 0.884p.
Remote Monitored Systems shares are traded on the London stock exchange's AIM market (the alternative investment market), which is the submarket specifically for smaller companies. AIM stocks are attractive to investors as they have tax advantages and smaller companies have the potential to benefit from rapid growth. But are RMS shares the best buy? Our stock market analysts regularly review the market and share their picks for high growth companies
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 75 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .